Share on LinkedInShare on LinkedIn

ARTICLE · 27 MARCH 2021

Challenges In Patenting Pharmaceutical Products In India

S&A Law Offices
S&A Law Offices
Contributor
S&A Law Offices

S&A Law Offices

S&A Law Offices (formerly Singh & Associates) is a full-services law firm comprising of...

View firm profile
Explore more from S&A Law Offices

This article looks into the challenges faced in the patenting of therapeutic antibodies in India.

IndiaIntellectual Property

This article looks into the challenges faced in the patenting of therapeutic antibodies in India. However, before going any further it is worthwhile to understand a little bit about the existing patenting process and practices followed in India in general and pharmaceuticals in particular.

The Indian Pharmaceutical industry is a successful and technology-oriented competent space that has seen some consistent growth over the last three decades. The current space comprises several private players who have captured substantial domestic market share and also benefit from factors such as favorable government policies and limited competition from overseas. However, as India gears up to be a global player, the dynamics of this industry are also changing where the domestic players will need to match the standards of the global market going forward. To this end efforts are being made in India to curb the problems of weak enforceability of existing intellectual property

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from